See also this year's filing and all EDGAR filings for this company.
PDF Report 0001341235_2017_Aldeyra_Therapeutics_Inc.pdf
Logs
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001341235', 'EntityCommonStockSharesOutstanding': 15131880, 'Assets': 25187679, 'AssetsCurrent': 25131327, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 3537862, 'LiabilitiesAndStockholdersEquity': 25187679, 'LiabilitiesCurrent': 2299238, 'LiabilitiesNoncurrent': 1238624, 'NetIncome': -18699450, 'PropertyPlantAndEquipmentNet': 56352, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 0, 'remainder_ComprehensiveNetIncome': 8490, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 21649817, 'remainder_NetIncome': -18699450, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001341235')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Edgar->Model Mapping
